These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20186684)

  • 21. Foam sclerotherapy for spouting haemorrhage in patients with varicose veins.
    Hamahata A; Yamaki T; Osada A; Fujisawa D; Sakurai H
    Eur J Vasc Endovasc Surg; 2011 Jun; 41(6):856-8. PubMed ID: 21420881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroscopy-guided endovenous foam sclerotherapy using a microcatheter in varicose tributaries followed by endovenous laser treatment of incompetent saphenous veins: technical feasibility and early results.
    Park SW; Yun IJ; Hwang JJ; Lee SA; Kim JS; Chang SH; Chee HK; Kim HC; Sun K; Park SJ
    Dermatol Surg; 2009 May; 35(5):804-12. PubMed ID: 19389098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microembolism during foam sclerotherapy of varicose veins.
    Ceulen RP; Sommer A; Vernooy K
    N Engl J Med; 2008 Apr; 358(14):1525-6. PubMed ID: 18385510
    [No Abstract]   [Full Text] [Related]  

  • 24. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
    Willenberg T; Smith PC; Shepherd A; Davies AH
    Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the current role of foam sclerotherapy in treating reflux and varicosities?
    Wright DD
    Semin Vasc Surg; 2010 Jun; 23(2):123-6. PubMed ID: 20685568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of microfoam sclerotherapy in a patient with Klippel-Trenaunay syndrome and a patent foramen ovale.
    Redondo P; Bastarrika G; Sierra A; Martínez-Cuesta A; Cabrera J
    Arch Dermatol; 2009 Oct; 145(10):1147-51. PubMed ID: 19841402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
    Rabe E; Pannier F
    Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foam sclerotherapy with enoxaparin prophylaxis in high-risk patients with postthrombotic syndrome.
    Reich-Schupke S; Doerler M; Altmeyer P; Stücker M
    Vasa; 2013 Jan; 42(1):50-5. PubMed ID: 23385226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foam and liquid sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009; 24 Suppl 1():62-72. PubMed ID: 19307442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Middle cerebral air embolism after foam sclerotherapy.
    Asbjornsen CB; Rogers CD; Russell BL
    Phlebology; 2012 Dec; 27(8):430-3. PubMed ID: 22368193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL; Wright DI;
    Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polidocanol foam sclerotherapy of persisting postoperative seromas after varicose vein surgery: a series of six cases.
    Moritz RK; Reich-Schupke S; Altmeyer P; Stücker M
    Phlebology; 2013 Oct; 28(7):341-6. PubMed ID: 22865419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke following variceal sclerotherapy.
    Hanisch F; Müller T; Krivokuca M; Winterholler M
    Eur J Med Res; 2004 May; 9(5):282-4. PubMed ID: 15257884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial infarction after ultrasoundguided foam sclerotherapy for varicose veins--a case report and review of the literature of a rare but serious adverse event.
    Engelberger RP; Ney B; Clair M; Dabiri A; Alatri A; Mazzolai L; Kern P
    Vasa; 2016; 45(3):255-8. PubMed ID: 27129073
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of side effects using carbon dioxide-oxygen foam for chemical ablation of superficial veins of the lower extremity.
    Morrison N; Neuhardt DL; Rogers CR; McEown J; Morrison T; Johnson E; Salles-Cunha SX
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):407-13. PubMed ID: 20547080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of polidocanol foam administration into rat peripheral veins on pulmonary parenchyma.
    de Moraes Silva MA; Ferreira RG; de Jesus-Silva SG; Cardoso RS; Miranda F
    Phlebology; 2018 Mar; 33(2):122-127. PubMed ID: 28092205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in venous function after foam sclerotherapy of varicose veins.
    Brunken A; Rabe E; Pannier F
    Phlebology; 2009 Aug; 24(4):145-50. PubMed ID: 19620696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of foam sclerotherapy for the treatment of varicose veins.
    Nael R; Rathbun S
    Vasc Med; 2010 Feb; 15(1):27-32. PubMed ID: 19797263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective randomized study comparing polidocanol foam sclerotherapy with surgical treatment of patients with primary chronic venous insufficiency and ulcer.
    Campos W; Torres IO; da Silva ES; Casella IB; Puech-Leão P
    Ann Vasc Surg; 2015 Aug; 29(6):1128-35. PubMed ID: 26004968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The French polidocanol study on long-term side effects: a survey covering 3,357 patient years.
    Guex JJ; Schliephake DE; Otto J; Mako S; Allaert FA
    Dermatol Surg; 2010 Jun; 36 Suppl 2():993-1003. PubMed ID: 20590706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.